We provide you with 20 years of free, institutional-grade data for WVE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of WVE. Explore the full financial landscape of WVE stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$2,626,744
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Verdine Gregory L. | Sale | -10,000 | $10 | $100,000 | 2025-08-26 |
| BOLNO PAUL | Sale | -217,351 | $10.1 | $2,194,810 | 2025-08-26 |
| Tan Aik Na | Sale | -21,000 | $9.25 | $194,250 | 2025-08-19 |
| Tan Aik Na | Derivatives Exercise | 21,000 | 2025-08-19 | ||
| Wagner Heidi L | Grant, award...etc | 12,700 | 2025-08-13 | ||
| HENRY CHRISTIAN O | Sale | -9,670 | $8.81 | $85,193 | 2025-08-13 |
| HENRY CHRISTIAN O | Grant, award...etc | 12,700 | 2025-08-13 | ||
| Rawcliffe Adrian | Grant, award...etc | 12,700 | 2025-08-13 | ||
| Verdine Gregory L. | Grant, award...etc | 12,700 | 2025-08-13 | ||
| CORRIGAN MARK | Grant, award...etc | 12,700 | 2025-08-13 | ||
| Tan Aik Na | Grant, award...etc | 25,400 | 2025-08-13 | ||
| RA CAPITAL MANAGEMENT, L.P. | Grant, award...etc | 12,700 | 2025-08-13 | ||
| TAKANASHI KEN | Grant, award...etc | 12,700 | 2025-08-13 | ||
| Tan Aik Na | Sale | -1,127 | $8.75 | $9,861 | 2025-08-07 |
| TAKANASHI KEN | Sale | -4,872 | $8.75 | $42,630 | 2025-08-07 |
| Verdine Gregory L. | Sale | -30,000 | $6.95 | $208,500 | 2025-06-13 |
| HENRY CHRISTIAN O | Sale | -10,500 | $9.77 | $102,575 | 2025-03-21 |
| HENRY CHRISTIAN O | Derivatives Exercise | 10,500 | 2025-03-21 | ||
| BOLNO PAUL | Sale | -169,025 | $9.57 | $1,617,569 | 2025-03-07 |
| BOLNO PAUL | Derivatives Exercise | 169,025 | 2025-03-07 | ||
| Verdine Gregory L. | Derivatives Exercise | 266,402 | 2025-03-07 | ||
| Vargeese Chandra | Derivatives Exercise | 91,754 | 2025-03-05 | ||
| BOLNO PAUL | Grant, award...etc | 121,000 | 2025-02-06 | ||
| Francis Chris | Grant, award...etc | 25,000 | 2025-02-06 | ||
| Moran Kyle | Grant, award...etc | 42,000 | 2025-02-06 | ||
| Vargeese Chandra | Grant, award...etc | 37,000 | 2025-02-06 | ||
| Vargeese Chandra | Derivatives Exercise | 46,000 | 2025-01-24 | ||
| BOLNO PAUL | Sale | -50,000 | $15 | $750,000 | 2024-11-27 |
| BOLNO PAUL | Derivatives Exercise | 50,000 | 2024-11-27 | ||
| BOLNO PAUL | Sale | -51,234 | $14.32 | $733,671 | 2024-11-15 |
| Francis Chris | Sale | -36,000 | $16 | $576,000 | 2024-11-13 |
| Francis Chris | Derivatives Exercise | 36,000 | 2024-11-13 | ||
| Francis Chris | Derivatives Exercise | 129,122 | 2024-10-18 | ||
| Francis Chris | Sale | -208,836 | $14 | $2,923,704 | 2024-10-18 |
| BOLNO PAUL | Sale | -90,474 | $15 | $1,357,110 | 2024-10-18 |
| Moran Kyle | Derivatives Exercise | 25,000 | 2024-10-11 | ||
| GSK plc | Open Market Purchase | 2,791,930 | $8 | 2024-10-01 | |
| Moran Kyle | Sale | -17,146 | $9 | $154,314 | 2024-09-27 |
| BOLNO PAUL | Sale | -48,366 | $5.78 | $279,555 | 2024-08-23 |
| CORRIGAN MARK | Grant, award...etc | 32,230 | 2024-08-14 | ||
| Verdine Gregory L. | Grant, award...etc | 16,115 | 2024-08-14 | ||
| TAKANASHI KEN | Grant, award...etc | 16,115 | 2024-08-14 | ||
| Wagner Heidi L | Grant, award...etc | 32,230 | 2024-08-14 | ||
| Rawcliffe Adrian | Grant, award...etc | 16,115 | 2024-08-14 | ||
| Tan Aik Na | Grant, award...etc | 16,115 | 2024-08-14 | ||
| HENRY CHRISTIAN O | Grant, award...etc | 16,115 | 2024-08-14 | ||
| RA CAPITAL MANAGEMENT, L.P. | Grant, award...etc | 16,115 | 2024-08-14 | ||
| Vargeese Chandra | Derivatives Exercise | 68,210 | 2024-07-24 | ||
| Moran Kyle | Sale | -15,630 | $6.17 | $96,421 | 2024-04-05 |
| GSK plc | Open Market Purchase | 3,300,000 | $5 | 2024-01-30 | |
| RA CAPITAL MANAGEMENT, L.P. | Open Market Purchase | 1,000,000 | $5 | 2024-01-17 | |
| RA CAPITAL MANAGEMENT, L.P. | Open Market Purchase | 1,000,000 | $5 | 2023-12-13 | |
| Moran Kyle | Sale | -37,062 | $4.75 | $176,119 | 2023-08-23 |
| Moran Kyle | Sale | -9,729 | $4.04 | $39,305 | 2023-02-17 |
| Vargeese Chandra | Sale | -10,249 | $4.03 | $41,303 | 2023-02-17 |
| BOLNO PAUL | Sale | -29,400 | $4.04 | $118,776 | 2023-02-17 |
| Francis Chris | Sale | -10,258 | $4.03 | $41,340 | 2023-02-17 |
The information provided in this report about WVE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Wave Life Sciences Ltd(NASDAQ:WVE) 
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides target ribonucleic acid to reduce the expression of ...
Website: http://www.wavelifesciences.com
Founded: 2012
Full Time Employees: 301
Sector: Healthcare
Industry: Biotechnology